Learning and Earning with Gateway Professional Education CME/CEU Webinar Series
|
|
- Garey McGee
- 5 years ago
- Views:
Transcription
1 Learning and Earning with Gateway Professional Education CME/CEU Webinar Series Best Practices for Colorectal Cancer Screening March 14, :00pm 1:00pm Robert A. Smith, PhD Vice President, Cancer Screening American Cancer Society Joe Mastalski Manager, Quality Improvement Gateway Health SM
2 Learning and Earning with Gateway Professional Education CME/CEU Webinar Series To receive CME/CEU credit for today s webinar: Call xxx-xxx-xxxx from the cell phone number you provided when you enrolled in the webinar series Enter code: **code would have been provided at time of live webinar** You MUST call by the end of the day today to receive credit! Next webinar: April 4, 2018 HPV and Cervical Cancer Forgot to enroll? Enroll today to get CME credit for attending our next webinar at Questions? us at ProviderEngagementTeam@GatewayHealthPlan.com This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Allegheny General Hospital and Gateway Health Plan. Allegheny General Hospital is accredited by the ACCME to provide continuing medical education for physicians. Allegheny General Hospital designates this live webinar activity for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 2
3 Shout Out! Washington Health System Washington, PA CTC: Carol Rhodes To arrange for a group viewing and lunch at your practice for a future webinar, please contact your Gateway Clinical Transformation Consultant (CTC). 3
4 Today s Presenters: Robert A. Smith PhD Vice President, Cancer Screening Joe Mastalski Manager, Quality Improvement American Cancer Society Quality Improvement Gateway Health SM 4
5 Screening for Colorectal Cancer Robert A. Smith, PhD Vice President, Cancer Screening, American Cancer Society Adjunct Professor of Epidemiology Emory University Rollins School of Public Health
6 Disclosures I have no financial disclosures or conflicts of interest to declare
7 Outline of Today s Presentation Recent trends Screening guidelines The screening tests, including strengths, limitations, and quality issues Strategies to increase screening rates Resources
8 Colorectal cancer screening reduces CRC mortality by finding cancer early, and by detecting and removing precursor lesions 1. Prevention Find and remove polyps to prevent cancer 2. Early Detection Find cancer in the early stages, when best chance for a cure
9 CRC Statistics Trends in Disease Rates & Screening Rates
10 Long-Term Trends in Colorectal Cancer Incidence ( ) and Mortality ( ) Rates* by Sex, United States. The dramatic declines in colorectal cancer incidence & mortality over the past decade have been attributed to the widespread uptake of colonoscopy screening, which increased from 19% in 2000 to 63% in 2015 among adults aged 50 to 75 years. Siegel RL, et al. CA Cancer J Clin 2017;67:
11 Trend in Colorectal Cancer Mortality: Age-standardized Rate vs. Number of Deaths, United States, The decline in death rates accelerated beginning around 2000, and notably has been of sufficient magnitude to overcome the aging and growth of the population Siegel RL, et al. CA Cancer J Clin 2017;67:
12 Decline in CRC Incidence and Mortality Decline due to: Screening earlier cancer detection improved survival Improvements in treatment Survival Rates by Disease Stage* 5-yr Survival % 70.4% 12.5% Local Regional Distant Stage of Detection
13 Colorectal Cancer Screening (%), Adults Ages 50 Years or Older, United States, 2015 Siegel RL, et al. CA Cancer J Clin 2017;67:
14 Colorectal Cancer Screening (%), Adults Ages 50 Years or Older, United States, 2015 Siegel RL, et al. CA Cancer J Clin 2017;67:
15 American Cancer Society and United States Preventive Services Task Force Guidelines for CRC Screening,
16 CRC Screening in Average Risk Adults: 2008 Recommendation ACS, USMSTF, ACR Stool Testing gfobt FIT mtsdna Flexible sigmoidoscopy Annual screening with high sensitivity (HS) gfobt or FIT, or Mt-sDNA every 3 years Low sensitivity gfobt not recommended Screening every 5 years Screening every 5 years, with annual gfobt or FIT is an option Colonoscopy Screening every 10 years CT Colonography Screening every 5 years
17 On June 20, 2016, the USPSTF released update CRC screening recommendations, providing an update of their 2008 recommendations The recommendations covered colorectal cancer screening with FOBT (gfobt, FIT, and FIT-DNA), endoscopy (colonoscopy and flexible sigmoidoscopy), and CT colonography Two tests not endorsed in the draft recommendations released in 2015 (FIT-DNA and CT colonography) were endorsed in the 2016 final recommendations. JAMA June 21, 2016 Volume 315, Number 23
18 USPSTF CRC Screening Recommendation Statement In the current recommendation, instead of emphasizing specific screening approaches, the USPSTF has instead chosen to highlight that there is convincing evidence that colorectal cancer screening substantially reduces deaths from the disease among adults aged 50 to 75 years and that not enough adults in the United States are using this effective preventive intervention. JAMA June 21, 2016 Volume 315, Number 23
19 USPSTF CRC Screening Recommendations, 2016 How does these changes compare with the 2008 ACS guideline? ACS endorses screening Q 3 yrs. Same ACS does not emphasize combined FSIG/FOBT JAMA June 21, 2016 Volume 315, Number 23
20
21 Screening for Colorectal Cancer Test Performance & Clinical Considerations
22 Stool Test: Guaiac (gfobt) Most common type of FOBT Best evidence (3 RCT s) 30 year f/u (NEJM Oct 2013) Need specimens from 3 bowel movements Non-specific Results influenced by foods and medications Older forms (Hemoccult II) not recommended! Better sensitivity with newer versions (Hemoccult Sensa)
23 Minnesota Colon Cancer Control Study 33,020 participants, with 30 years of follow-up Rehydrated guaiac based FOBT Screening reduced colorectal-cancer mortality Relative risk for annual screening: 0.68; (95% CI, 0.56 to 0.82) Relative risk for biennial screening: 0.78; (95% CI, 0.65 to 0.93) Conclusion: After 30 years of follow-up, an invitation to annual FOBT screening was associated with 32% fewer CRC deaths, and a biennial invitation was associated with 22% fewer deaths
24 Minnesota FOBT Trial Comparative Incidence in the Invited & Control Group Screening with FOBT is associated with a reduction in incidence of colorectal cancer 18 yrs. after randomization, there was 20% lower CRC incidence in the annual screening group Annual group = 32/1,000 Control group = 39/1,000 In the Minnesota Trial, there was a high colonoscopy referral rate due to the use of rehydrated FOBT
25 Single Test Performance Characteristics of gfobt Variants: Hemoccult & Hemoccult II Low test sensitivity (vs. program sensitivity) Sensitivity improved with rehydration, but specificity suffers Dietary restrictions reduce patient adherence Interpretation of test results is subjective Lower patient completion compared with FIT NOT RECOMMENDED BY ACS or USPSTF FOR CRC SCREENING Study with One-Time Testing Collins, et al. AIM, 2005 Lieberman, et al. NEJM, 2001 Imperiale, et al. NEJM, 2004 Allison, et al. NEJM, 1996 Sensitivity for Cancer 9.5% [ In Office, Single Panel gfobt] 50% (w/rehydration) Specificity 97.5% 93.8% 14.1% 95.2% 37.1% 97.7%
26 Single Panel FOBT Following Digital Rectal Exam In-Office FOBT is common CRC screening strategy Reasons to STOP single sample FOBT Not recommended by any CRC screening guideline Not recommended by the manufacturer of any test Lowest sensitivity of all CRC screening tests, i.e., less than 5% for advanced neoplasia
27 Stool Test: Immunochemical (FIT) Slightly more costly than guaiac tests Higher sensitivity for cancer & adenomas than guaiac-based FOBT Specific for human blood and for lower GI bleeding Results not influenced by foods or medications Most types require only 1 or 2 stool specimens Patients prefer FIT to gfobt Test Completion Rate is Higher!!
28 Meta-analysis of FIT vs. Hemoccult Sensa FIT Hemoccult Sensa Sensitivity: 73-89% 64-80% Specificity: 92-95% 87-90% Two Key Points: 1. Only high sensitivity stool tests are recommended for screening 2. FIT is a superior option for annual stool testing. Lee, JK et. al. Ann Intern Med (3): 171
29 Adherence with FIT is consistently better than with guaiac-based stool tests Adherence Study FIT Guaiac Hoffman (2010) 61.4% 50.5% Hol (2010) 61.5% 49.5% Van Rossum (2008) 59.6% 49.6% Cole (2003) 39.6% 23.4% Source: TR Levin, MD
30 Multi-Target Stool DNA Test Only one test currently available (Cologuard) Combines tests for stool DNA markers associated with cancers and adenomas plus an FIT
31 NEJM 2014
32 Cologuard Guidelines & Coverage FDA has cleared it for marketing as CRC screening test Q 3 years CMS has agreed to cover Cologuard for average risk Medicare beneficiaries age yrs Medicare will reimburse ~ $500 Q 3 yrs. for the test (price includes navigation component) Private insurance coverage limited All positive tests must be evaluated by colonoscopy Included in current ACS guidelines, and USPSTF recommendations
33 Colonoscopy Allows direct visualization of entire colon lumen Screening, diagnostic and therapeutic 10 yr. interval The most common screening test in US (>80%)
34 Colonoscopy Polypectomy prevents colorectal cancer The National Polyp Study observed a 76-90% reduction in CRC incidence after polypectomy Winawer et al, NEJM 1993
35 Long-Term Colorectal-Cancer incidence and Mortality after Lower Endoscopy Data from two prospective cohort studies: the Nurses Health Study, which included 121,700 U.S. female nurses, 30 to 55 years of age at enrollment in 1976; the Health Professionals Follow-up Study, which included 51,529 U.S. male health professionals, 40 to 75 years of age at enrollment in Examined the association between lower endoscopy ( ) and colorectal cancer incidence and mortality through June 2012.
36 Long-Term Colorectal-Cancer incidence and Mortality after Lower Endoscopy NEJM, 2013, vol. 369 no. 12
37 Quality Issues with Colonoscopy Poor pre-procedure documentation Poor prep Failure to reach the cecum Rapid withdrawal time Adverse events Highly variable adenoma detection rate Interval cancers Over and under utilization of the procedure Highly variable reports Poor feedback Most endoscopists are unaware of their numbers, since most facilities do not track their data.
38 What do the quality data on colonoscopy reveal? Adenoma detection rate (ADR) is highly variable. In one large series, ADR varied from 7% - 52% 8% interval cancer rate ADR inversely associated with the interval cancer rate ADR inversely associated with colorectal cancer death
39 Variability in the Adenoma Detection Rate is 10 fold, and is Associated with Withdrawal Time Barclay et al. NEJM;2006;355:2533
40 Adenoma Detection Rate and Risk of CRC Incidence, Interval Cancer, and Death Setting: Kaiser Permanente of Northern California 264,972 Colonoscopies among 223,842 patients were eligible for assessment 927,523 person-years of follow-up and detection of 712 interval CRCs) Outcome: Risk of CRC 6 months to 10 years after colonoscopy
41 Hazard ratios for ADR and risk of advanced stage CRC, and fatal CRC Advance Stage CRC Fatal CRC
42 Key Quality Indicators Adenoma Detection Rate (ADR) Entire Unit and Individual Endoscopists Improvement plans are initiated if ADR rate is not 25% for men and 15% for women, or > 20% overall Cecal Intubation Rate (CIR) Improvement plans are initiated if complete colonoscopy is not accomplished in > 90% of all patients and > 95% of those undergoing screening and surveillance procedures, for both the unit as a whole and for each individual endoscopist Quality of Preparation Improvement plans are initiated if prep quality is not adequate for detection of all polyps > 5 mm in > 90% of patients.
43 Key Quality Indicators Complete Procedure Documentation Patient demographics ASA Score (assessment of procedural risk) Procedure Indications (screening, surveillance, symptoms, etc.) Procedural Technical Description (medications, extent of exam, adequacy of preparation, ease and tolerance, retroflexion, other maneuvers) Colonoscopic Findings Diagnosis and Assessment Unplanned Events Follow-up Plan Incomplete unit or endoscopist documentation shall initiate improvement plan
44 Recommended, But Less Common CRC Screening Tests 44
45 Flexible Sigmoidoscopy The scope on the right is a 60 cm flexible scope. Others include smaller 35 cm flexible scope, and the 25 cm rigid scope.
46 Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial 14 UK centers 170,432 eligible men and women 57,237 to the intervention group, of which 71% underwent a single flexible sigmoidoscopy Outcomes of interest: Colorectal cancer incidence Colorectal cancer mortality Findings: 23% reduced incidence 31% reduced mortality
47 Radiographic CRC Screening Tests Double Contrast Barium Enema CT Colonography, aka Virtual Colonoscopy
48 Results: For all samples, sensitivity of Plasma Septin9 for CRC detection was 73.3%, and 68.0% for FIT. Specificity of the Plasma Septin9 test was 81.5% compared with 97.4% for FIT. When test results for Plasma Septin9 and FIT were combined, CRC detection was 88.7% at a specificity of 78.8%. Conclusions: At a sensitivity of 72%, the Plasma Septin9 test is non- inferior to FIT for CRC detection, although at a lower specificity. PLOS ONE 1 June 2014 Volume 9 Issue 6 e98238
49 Improving Colorectal Cancer Screening Rates Offer Your Patients the Option of Colonoscopy OR FOBT
50 Colonoscopy should be regarded as an effective screening test, not the best screening test for all adults While colonoscopy is viewed as the best screening test, many patients face barriers or are not willing to undergo colonoscopy Often recommended despite access or other challenges Focus on colonoscopy associated with low screening rates in a number of studies Patient preferences rarely solicited
51 Primary Care Provider Perceptions of Screening Tests FOBT/FIT used, but: Effectiveness questioned by many clinicians Lack of knowledge re: performance of new vs. older forms of stool tests, other quality issues
52 Benefits, Harms, and Burdens of Recommended Screening Strategies Over a Lifetime Source: CISNET, 2015
53 Many Patients Prefer FOBT Randomized clinical trial in which 997 patients in the San Francisco PH care system received different recommendations for screening: Recommended Test Colonoscopy 38% FOBT 67% Colonoscopy or FOBT 69% Completed Screening Many patients will forgo screening if they are not offered an alternative to colonoscopy. (Inadomi et al. 2012)
54 Many Patients Prefer FOBT/FIT Diverse sample of 323 adults given detailed side-by-side description of FOBT and colonoscopy (DeBourcy et al. 2007) 53% preferred FOBT 212 patients at 4 health centers rated different screening options with different attributes (Hawley et al. 2008) 37% preferred colonoscopy 31% preferred FOBT Nationally representative sample of 2068 VA patients given brief descriptions of each screening mode (Powell et al. 2009) 37% preferred colonoscopy 29% preferred FOBT
55 Summary--Advantages of Stool Tests Newer tests are very accurate Preferred by a significant % of patients Less expensive No bowel preparation. Done in privacy at home. No need for time off work or assistance getting home after the procedure. Non-invasive no risk of pain, bleeding, perforation Limits need for colonoscopies required only if stool blood testing is abnormal.
56 Improving Colorectal Cancer Screening Rates Take Advantage of Checkups to Refer for CRC Screening
57 Cancer Screening & the Periodic Preventive Health Exam Retrospective cohort study 64,288 adults ages in a managed care plan Outcomes focused on completion of: CRC screening Breast cancer screening Prostate cancer screening
58 Adjusted Incidence of 3 Cancer Screening Tests by Receipt of Preventive Health Exam (PHE) CRC Screening Mammography PSA Testing Received PHE Did Not Receive PHE Approximately 50% of adults who had received a PHE completed CRC screening within 5 annual visits
59 Improving Colorectal Cancer Screening Rates Expand Opportunities for CRC Screening During the Delivery of Other Preventive Care
60 Flu-FIT is an intervention designed to use the opportunity when adults are receiving flu shots to promote colorectal cancer screening
61 CRC Screening Outreach During Annual Flu Shot Activities Potential Benefits of Flu-FOBT or Flu-FIT Programs: Reaches patients at a time each year when they are already thinking about prevention Creates a seasonal focus on cancer screening that may add to other screening efforts Time-efficient way to involve non-physician staff in screening activities Educates patients that just like a flu shot, you need FOBT/FIT every year Slide courtesy of M. Potter, MD
62 San Francisco General Hospital Randomized Trial (Flu shot clinic attendees randomized to Flu Only vs. Flu + FOBT on different dates included telephone follow-up for FOBT recipients) FLU Only FLU + FOBT (N=268) (N= 246) Up-to-Date Before Flu 52.9% 54.5% Season Up-to-Date After Flu Season 57.3% 84.3% Change: (p<0.001) +4.4 % % Ann Fam Med, 2009
63 Improving Colorectal Cancer Screening Rates Make CRC Screening a Practice Priority and Implement Evidence-Based Interventions to Improve Screening Rates
64 Action Plan Toolkit Version This 8 page guide introduces clinicians and staff to concepts and tools provided in the full Toolkit Contains links to the full Toolkit, tools and resources Not colorectal-specific; practical, action-oriented assistance that can be used in the office to improve screening rates for multiple cancer sites (colorectal, breast and cervical) Available at
65 Communication
66 Clinician Reminder Systems Are Essential!! Chart Prompts Problem lists Screening schedules Integrated summaries Alerts Flags placed in chart Follow-Up Reminders Tickler System Logs and Tracking Electronic Reminder Systems
67 Colorectal Cancer Screening Uptake among Patients Receiving Usual Care in the Systems of Support to Increase Colorectal Cancer Screening Trial, by Exposure to a Patient-Centered Medical Home Patients in PCMHs 8 months or longer were 29% more likely to receive CRC screening than patients with fewer months in the PCMH
68 What is State of the Art Colorectal Cancer Screening? Take and regularly update family history Include maternal and paternal sides for 3 generations Counsel your patients about signs and symptoms of colorectal cancer Follow ACS or USPSTF guidelines, with particular attention to adherence Offer your patients colonoscopy AND a high sensitivity FOBT, preferably FIT Identify a screening services with gastroenterologists who track their performance
69
70 High Quality Stool Testing Clinicians Reference: FOBT One page document designed to educate clinicians about important elements of colorectal cancer screening using fecal occult blood tests (FOBT). Provides state-of-the-science information about guaiac and immunochemical FOBT, test performance and characteristics of high quality screening programs. Available at
71 NCCRT Tools, Resources and Publications Available at: nccrt.org
72
73
74 Thank you
75 Colorectal Cancer Screening Initiatives Joseph Mastalski, Manager, Quality Improvement 1 DATE PRESENTED BY:
76 HEDIS Measure Looks at the percentage of Medicare members who are up to date with screening Target Population Men and women Ages years No history of colorectal cancer or total colectomy 76 DATE PRESENTED BY:
77 HEDIS Measure There are currently 5 acceptable tests for screening: Fecal Occult Blood Test (FOBT) Every year Flexible Sigmoidoscopy Every 5 years Colonoscopy Every 10 years CT Colonography* - Every 5 years FIT-DNA Test Every 3 years *CT Colonography is not currently covered by Gateway Health 77 DATE PRESENTED BY:
78 Member Outreach and Education Interactive Voice Response (IVR)/ / SMS campaigns focused around education, screening reminders and appointment scheduling Cobranded letter with the American Cancer Society Social media posts and newsletter articles Annual ifobt campaign 78 DATE PRESENTED BY:
79 Provider Initiatives Practice reference guide with HEDIS specifications and helpful tips Clinical Transformation Consultant support Gateway to Practitioner Excellence (GPE ) provider incentive 79 DATE PRESENTED BY:
80 2017 GPE Program* Follows the HEDIS specification: Members ages years of age who receive an appropriate screening No history of colorectal cancer or total colectomy $10 per member per year for submission of a CPT/HCPCS code for screening The CPT/HCPCS codes do not need to be submitted by the PCP. Credit is given for getting the member screened. *2018 program is currently being developed 80 DATE PRESENTED BY:
81 Applicable Codes for GPE Definition CPT Category I HCPCS Colonoscopy G0105, G0121 Flexible Sigmoidoscopy G0104 FOBT 82270, G0328 FIT-DNA Test G DATE PRESENTED BY:
82 Learning and Earning with Gateway Professional Education CME/CEU Webinar Series To receive CME/CEU credit for today s webinar: Call xxx-xxx-xxxx from the cell phone number you provided when you enrolled in the webinar series Enter code: **code would have been provided at time of live webinar** You MUST call by the end of the day today to receive credit! Next webinar: April 4, 2018 HPV and Cervical Cancer Forgot to enroll? Enroll today to get CME credit for attending our next webinar at Questions? us at ProviderEngagementTeam@GatewayHealthPlan.com This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Allegheny General Hospital and Gateway Health Plan. Allegheny General Hospital is accredited by the ACCME to provide continuing medical education for physicians. Allegheny General Hospital designates this live webinar activity for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 82
83 Slides will be posted at (CME credit only for enrolled participants in live webinar) 83
The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean?
The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean? Robert A. Smith, PhD Cancer Control, Department of Prevention and Early Detection American Cancer Society
More informationImproving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC)
Improving Outcomes in Colorectal Cancer: The Science of Screening Tennessee Primary Care Association October 23, 2014 Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancers Colorectal Cancer
More informationColorectal Cancer Screening: State of the Science
Colorectal Cancer Screening: State of the Science LA Academy of Family Practice Convention July 9, 2016 Sandestin, FL Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancers Colorectal Cancer
More informationColorectal Cancer Screening: The Science Behind the Guidelines. CRC Incidence North Dakota. Colorectal Cancer (CRC) CRC Incidence North Dakota
Reaching 80% Screened For Colorectal Cancer by 2018: Using Systems Change to Increase Cancer Screening Colorectal Cancer Screening: The Science Behind the Guidelines September 2017 Jeff Hostetter, MD Based
More informationColorectal Cancer Screening in Ohio CHCs. Ohio Association of Community Health Centers
Colorectal Cancer Screening in Ohio CHCs Ohio Association of Community Health Centers 2 1/29/2015 Your Speakers Dr. Ted Wymyslo Ashley Ballard Randy Runyon 3 1/29/2015 Facts 3 rd most common cancer in
More informationLearning and Earning with Gateway Professional Education CME/CEU Webinar Series. Breast Cancer Screening September 21, :00pm 1:00pm
Learning and Earning with Gateway Professional Education CME/CEU Webinar Series Breast Cancer Screening September 21, 2017 12:00pm 1:00pm Robert A. Smith, PhD Vice President, Cancer Screening American
More informationHOW TO EVALUATE ACTIVITIES INTENDED TO INCREASE AWARENESS AND USE OF COLORECTAL CANCER SCREENING. Using your toolkit to conduct an evaluation
EVALUATION TOOLKIT HOW TO EVALUATE ACTIVITIES INTENDED TO INCREASE AWARENESS AND USE OF COLORECTAL CANCER SCREENING Using your toolkit to conduct an evaluation Welcome Mary Doroshenk, MA Director National
More informationGuidance on Implementing FIT-based Screening Programs. June 29th, :00pm ET
Guidance on Implementing FIT-based Screening Programs June 29th, 2016 12:00pm ET Presenters: Emily Bell, MPH (Moderator) NCCRT Associate Director Durado Brooks, MD, MPH Managing Director, Cancer Control
More informationOvercoming Barriers to Cancer Screening. Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancer American Cancer Society
Overcoming Barriers to Cancer Screening Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancer American Cancer Society Cancer Disparities Cancer Disparities: A Definition Cancer health disparities
More informationColorectal Cancer Screening. Paul Berg MD
Colorectal Cancer Screening Paul Berg MD What is clinical integration? AMA Definition The means to facilitate the coordination of patient care across conditions, providers, settings, and time in order
More information11/9/2015 OUTLINE. Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist
Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist Anil K Sharma MD FACP Professor of Clinical Medicine, University of Rochester Chief of Gastroenterology,
More informationIncreasing Colorectal Cancer Screening in Wyoming. Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program
Increasing Colorectal Cancer Screening in Wyoming Allie Bain, MPH Outreach & Education Supervisor Wyoming Integrated Cancer Services Program Overview What is colorectal cancer? What are risk factors for
More informationColorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem
Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls Disclosures: None Jonathan P. Terdiman, M.D. Professor of Clinical Medicine University of California, San Francisco CRC: still a major public
More informationFinancial Disclosers
Slide 1 Colorectal Cancer Screening Jason Hemming, MD NESGNA November 15, 2014 Slide 2 Bio Slide 3 Financial Disclosers I have no actual or potential conflict of interest relation to this presentation
More informationColon Screening in 2014 Offering Patients a Choice. Clark A Harrison MD The Nevada Colon Cancer Partnership
Colon Screening in 2014 Offering Patients a Choice Clark A Harrison MD The Nevada Colon Cancer Partnership Objectives 1. Understand the incidence and mortality rates for CRC in the US. 2. Understand risk
More informationColorectal Cancer Screening in Later Life: Blum Center Rounds
Colorectal Cancer Screening in Later Life: Blum Center Rounds OCTOBER 10, 2018 Agenda CRC Screening and Surveillance Recommendation Screening for Colon Cancer later in life Discussion and listening Families
More informationScreening & Surveillance Guidelines
Chapter 2 Screening & Surveillance Guidelines I. Eligibility Coloradans ages 50 and older (average risk) or under 50 at elevated risk for colon cancer (personal or family history) that meet the following
More informationUpdates in Colorectal Cancer Screening & Prevention
Updates in Colorectal Cancer Screening & Prevention Swati G. Patel, MD MS Assistant Professor of Medicine Division of Gastroenterology & Hepatology Gastrointestinal Cancer Risk and Prevention Clinic University
More informationCRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC
10:45 11:45 am Guide to Colorectal Cancer Screening SPEAKER Howard Manten M.D. Presenter Disclosure Information The following relationships exist related to this presentation: Howard Manten MD: No financial
More informationColorectal Cancer Screening Guideline Issue Brief Updated May 30 th, 2018
Colorectal Cancer Screening Guideline Issue Brief Updated May 30 th, 2018 Issue Summary The American Cancer Society has updated its colorectal screening guideline, which have been published in CA: A Journal
More informationPage 1. Selected Controversies. Cancer Screening! Selected Controversies. Breast Cancer Screening. ! Using Best Evidence to Guide Practice!
Cancer Screening!! Using Best Evidence to Guide Practice! Judith M.E. Walsh, MD, MPH! Division of General Internal Medicine! Womenʼs Health Center of Excellence University of California, San Francisco!
More informationObjectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background
Colorectal Cancer Screening Payam Afshar, MS, MD Kaiser Permanente, San Diego Objectives Colorectal cancer background Colorectal cancer screening populations Colorectal cancer screening modalities Colonoscopy
More informationCOLON CANCER SCREENING: AN UPDATE
Overview COLON CANCER SCREENING: AN UPDATE Siddharth Verma, DO, JD Rutgers New Jersey Medical School Background Screening Updates in Specific Populations African Americans CRC in the younger age USPSTF
More informationACS FluFOBT Program A Proven Approach to Increase Colorectal Cancer Screening
ACS FluFOBT Program A Proven Approach to Increase Colorectal Cancer Screening Massachusetts Annual Adult Immunization Conference April 27,2016 Terry E Shlimbaum, MD New York State Chief Medical Officer
More informationColorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005
Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005 David Lieberman MD Chief, Division of Gastroenterology Oregon Health and Science University Portland VAMC Portland, Oregon
More informationPositive Results on Fecal Blood Tests
Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests Results of a systematic review and Kaiser experience Kevin Selby, M.D. kevin.j.selby@kp.org National Colorectal Cancer Roundtable
More informationColorectal Cancer Screening. Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital
Colorectal Cancer Screening Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital March, 2018 CRC Epidemiology 4th most common malignancy in US (136,000 cases/yr) 2nd
More informationCancer Screening 2009: New Tests, New Choices
Objectives Cancer Screening 2009: New Tests, New Choices UCSF Annual Review in Family Medicine April 21, 2009 Michael B. Potter, MD Professor, Clinical Family and Community Medicine UCSF School of Medicine
More informationThank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements
Thank You to Our Sponsors: University at Albany School of Public Health NYS Department of Health Evaluations & CE Credits Nursing Contact Hours, CME and CHES credits are available. Please visit www.phlive.org
More informationColorectal Cancer Screening and Surveillance
1 Colorectal Cancer Screening and Surveillance Jeffrey Lee MD, MAS Assistant Clinical Professor of Medicine University of California, San Francisco jeff.lee@ucsf.edu Objectives Review the various colorectal
More informationColorectal Cancer Screening and Risk Assessment Workflow. Documentation Guide for Health Center NextGen Users
Colorectal Cancer Screening and Risk Assessment Workflow Documentation Guide for Health Center NextGen Users Colorectal Cancer Screening and Risk Assessment Workflow and Documentation Guide for Health
More information2. Describe pros/cons of screening interventions (including colonoscopy, CT colography, fecal tests)
Learning Objectives 1. Review principles of colon adenoma/cancer biology that permit successful prevention regimes 2. Describe pros/cons of screening interventions (including colonoscopy, CT colography,
More informationColorectal Cancer Screening: A Clinical Update
11:05 11:45am Colorectal Cancer Screening: A Clinical Update SPEAKER Kevin A. Ghassemi, MD Presenter Disclosure Information The following relationships exist related to this presentation: Kevin A. Ghassemi,
More informationPage 1. Cancer Screening for Women I have no conflicts of interest. Overview. Breast, Colon, and Lung Cancer. Jeffrey A.
Cancer Screening for Women 2017 Breast, Colon, and Lung Cancer Jeffrey A. Tice, MD Professor of Medicine Division of General Internal Medicine University of California, San Francisco I have no conflicts
More informationCLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING
CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING This guideline is designed to assist practitioners by providing the framework for colorectal cancer (CRC) screening, and is not intended to replace
More informationInterventions to Improve Follow-up of Positive Results on Fecal Blood Tests
Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests Results of a systematic review, Kaiser experience, and implications for the Canton of Vaud Kevin Selby, M.D. Kevin.Selby@hospvd.ch
More informationColorectal Cancer Screening
Colorectal Cancer Screening Colorectal cancer is preventable. Routine screening can reduce deaths through the early diagnosis and removal of pre-cancerous polyps. Screening saves lives, but only if people
More informationACG Clinical Guideline: Colorectal Cancer Screening
ACG Clinical Guideline: Colorectal Cancer Screening Douglas K. Rex, MD, FACG 1, David A. Johnson, MD, FACG 2, Joseph C. Anderson, MD 3, Phillip S. Schoenfeld, MD, MSEd, MSc (Epi), FACG 4, Carol A. Burke,
More informationThe choice of methods for Colorectal Cancer Screening; The Dutch experience
The choice of methods for Colorectal Cancer Screening; The Dutch experience Monique van Leerdam, Gastroenterologist, NKI-AVL, Amsterdam The Netherlands Colorectal cancer CRC 2 nd cause of cancer related
More informationObjectives. 80% by A Pledge is Just the First Step. Thank You, ND Pledge Signers! What will it really take?
Making a Difference: How Stakeholders are Working Together to Increase Colorectal Cancer Screening in North Dakota Joyce Sayler, Community Partnership Coordinator, NDDoH Tasha Peltier, Quality Improvement
More informationIncreasing Colorectal Cancer Screening Rates Why it s not as easy as you ve been told
INCREASING COLORECTAL CANCER SCREENING IN NYS Increasing Colorectal Cancer Screening Rates Why it s not as easy as you ve been told 5/15/17 Syracuse, NY Martin C. Mahoney, MD, PhD Roswell Park Cancer Institute
More informationDebate: General surveillance/screening for colon cancer in a resource constrained environment is imperative
Debate: General surveillance/screening for colon cancer in a resource constrained environment is imperative Dr. Meryl Oyomno Department of surgery, University of Pretoria INTRODUCTION Screening is the
More informationColon Cancer Screening. A Provider Opinion Survey
Colon Cancer Screening A Provider Opinion Survey 1. Background Information What is colon cancer? Who needs to be screened? Colorectal Cancer» Presence of abnormal cells in the colon or rectum that divide
More informationCancer Screenings and Early Diagnostics
Cancer Screenings and Early Diagnostics Ankur R. Parikh, D.O. Medical Director, Center for Advanced Individual Medicine Hematologist/Medical Oncologist Atlantic Regional Osteopathic Convention April 6
More informationEarly detection and screening for colorectal neoplasia
Early detection and screening for colorectal neoplasia Robert S. Bresalier Department of Gastroenterology, Hepatology and Nutrition. The University of Texas. MD Anderson Cancer Center. Houston, Texas U.S.A.
More informationCENTERS FOR DISEASE CONTROL AND PREVENTION CENTERS FOR DISEASE CONTROL AND PREVENTION. Incidence Male. Incidence Female.
A Call to Action: Prevention and Early Detection of Colorectal Cancer (CRC) 5 Key Messages Screening reduces mortality from CRC All persons aged 50 years and older should begin regular screening High-risk
More informationColorectal cancer screening
26 Colorectal cancer screening BETHAN GRAF AND JOHN MARTIN Colorectal cancer is theoretically a preventable disease and is ideally suited to a population screening programme, as there is a long premalignant
More informationCologuard Screening for Colorectal Cancer
Pending Policies - Medicine Cologuard Screening for Colorectal Cancer Print Number: MED208.056 Effective Date: 08-15-2016 Coverage: I.Cologuard stool DNA testing may be considered medically necessary for
More informationColon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011
Colon Cancer Screening and Surveillance Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colorectal Cancer Preventable cancer Number 2 cancer killer in the USA Often curable if detected
More informationColorectal Cancer Screening
Colorectal Cancer Screening December 5, 2017 Connecticut Cancer Partnership 14th Annual Meeting Xavier Llor, M.D., PhD. Associate Professor of Medicine Co-Director, Cancer Genetics and Prevention Program
More informationACS Colorectal Cancer Screening Guideline for Average Risk Adults 2018
ACS Colorectal Cancer Screening Guideline for Average Risk Adults 2018 1 How are Cancer Screening Guidelines Developed? ACS Guideline Development Process Systematic Evidence Review & Modeling Reports [existing
More informationColorectal Cancer: Screening & Surveillance
Objectives Colorectal Cancer: Screening & Surveillance Chanda K. Ho, MD MPH Advances in Internal Medicine Brief overview epidemiology and pathogenesis of colorectal cancer (CRC) To review screening modalities
More informationBe it Resolved that FIT is the Best Way to Screen for Colorectal Cancer DEBATE
Be it Resolved that FIT is the Best Way to Screen for Colorectal Cancer DEBATE DEBATE Presenters PRESENTATION MODERATOR Dr. Praveen Bansal -MD, CCFP FCFP Regional Primary Care Lead, Integrated Cancer Screening,
More informationAchieving 80% by 2018: Working Together Can Get Us There. Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016
Achieving 80% by 2018: Working Together Can Get Us There Zachary Gregg, MD Sentara Martha Jefferson April 18, 2016 1 Prostate 21% Lung & bronchus 14% Colon & rectum 8% Urinary bladder 7% Melanoma of skin
More informationSelected Controversies. Cancer Screening. Breast Cancer Screening. Selected Controversies. Page 1. Using Best Evidence to Guide Practice
Cancer Screening Using Best Evidence to Guide Practice Judith M.E. Walsh, MD, MH Division of General Internal Medicine Women s Health Center of Excellence University of California, San Francisco Selected
More informationWellness Along the Cancer Journey: Healthy Habits and Cancer Screening Revised October 2015 Chapter 7: Cancer Screening and Early Detection of Cancer
Wellness Along the Cancer Journey: Healthy Habits and Cancer Screening Revised October 2015 Chapter 7: Cancer Screening and Early Detection of Cancer Healthy Habits and Cancer Screening Rev 10.20.15 Page
More informationRecommendations on Screening for Colorectal Cancer 2016
Recommendations on Screening for Colorectal Cancer 2016 Canadian Task Force on Preventive Health Care (CTFPHC) Putting Prevention into Practice Canadian Task Force on Preventive Health Care Groupe d étude
More informationCT Colonography. A Radiologist s View of the Colon from Outside-In. Donny Baek, MD
CT Colonography A Radiologist s View of the Colon from Outside-In Donny Baek, MD Computed Tomography (CT) CT Image Reconstruction CT Image Reconstruction CT Image Reconstruction Colorectal Cancer Annual
More informationGuidelines for the Early Detection of Cancer
Guidelines for the Early Detection of Cancer The American Cancer Society recommends these cancer screening guidelines for most adults. Screening tests are used to find cancer before a person has any symptoms.
More informationCOLORECTAL CANCER. Colorectal Cancer (CRC) 3 rd most common cancer in U.S. 3 rd deadliest cancer in U.S. 12/4/2014
The heart and science of medicine. UVMHealth.org/CancerCenter COLORECTAL CANCER Claire Verschraegen, MD Co-Director University of Vermont Cancer Center 1 Colorectal Cancer (CRC) 3 rd most common cancer
More informationHow to start a screening Program? WEO Colorectal Cancer Screening Committee Meeting Brasilia Nov R. Sáenz, FACG,FASGE
How to start a screening Program? WEO Colorectal Cancer Screening Committee Meeting Brasilia Nov 11 2017 R. Sáenz, FACG,FASGE Wheel has been discovered already Policy Planning Thanks to GBD Big Data CRC
More informationHOW TO ASSURE FOLLOW UP COLONOSCOPY FOR POSITIVE FIT FROM THE PROCESS SIDE JANUARY 30 TH, :00 PM ET
HOW TO ASSURE FOLLOW UP COLONOSCOPY FOR POSITIVE FIT FROM THE PROCESS SIDE JANUARY 30 TH, 2018 1:00 PM ET 1 Purpose of Todays Webinar Review evidence and processes to help ensure that patients obtain a
More informationDeveloping Systems to Increase Colorectal Cancer Screening at Health Centers
Northwestern University Feinberg School of Medicine Developing Systems to Increase Colorectal Cancer Screening at Health Centers David R. Buchanan, MD, MS Chief Clinical Officer, Erie Family Health Center
More informationCitation for published version (APA): Wijkerslooth de Weerdesteyn, T. R. (2013). Population screening for colorectal cancer by colonoscopy
UvA-DARE (Digital Academic Repository) Population screening for colorectal cancer by colonoscopy de Wijkerslooth, T.R. Link to publication Citation for published version (APA): Wijkerslooth de Weerdesteyn,
More informationColorectal Cancer Screening. Dr Kishor Muniyappa 2626 Care Drive, Suite 101 Tallahassee, FL Ph:
Colorectal Cancer Screening Dr Kishor Muniyappa 2626 Care Drive, Suite 101 Tallahassee, FL 32308 Ph: 850-297-0351 What we ll be talking about How common is colorectal cancer? What is colorectal cancer?
More informationGuidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer
Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer David A. Lieberman, 1 Douglas K. Rex, 2 Sidney J. Winawer,
More informationPage 1. Controversies in Cancer Prevention and Screening. Disclosures. Screening. Principles of Screening. I have no conflicts of interest
Controversies in Cancer Prevention and Screening Disclosures Using the Best Evidence in 2015 I have no conflicts of interest Judith M.E. Walsh, MD, MPH Division of General Internal Medicine Women s Health
More informationOntario s New Colorectal Cancer Screening Program. OHA May 15, 2007
Ontario s New Colorectal Cancer Screening Program OHA May 15, 2007 Outline The Context Facts About Colorectal Cancer Research and Background Information The CRC Screening Program Average Risk Screening
More informationBackground and Rationale for Gipson bill AB The imperative for colonoscopy after a positive FOBT (Fecal Occult Blood Test)
Background and Rationale for Gipson bill AB 1763 The imperative for colonoscopy after a positive FOBT (Fecal Occult Blood Test) The Affordable Care Act (ACA) requires all private insurers (except grandfathered
More informationExemplary Primary Care Practices 80% by 2018 Mini Webinar Series. November 10th, :00pm EST
Exemplary Primary Care Practices 80% by 2018 Mini Webinar Series November 10th, 2015 1:00pm EST Purpose of Today s Webinar Examine best practices that primary care providers and practices can undertake
More informationColorectal cancer screening A puzzle of tests and strategies
Colorectal cancer screening A puzzle of tests and strategies A. Van Gossum, MD, PhD Head of the Clinic of Intestinal Diseases and Nutritional Support Department of Gastroenterology Hôpital Erasme ULB -
More informationIncreasing Screening Rates in Practice. Francis R Colangelo MD, FACP February 21, 2017
Increasing Screening Rates in Practice Francis R Colangelo MD, FACP February 21, 2017 Purpose of Today s Webinar To maximize options for improving colon cancer screening by following four essential strategies
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS What is CRC? CRC (CRC) is cancer of the large intestine (colon), the lower part of the digestive system. Rectal cancer is cancer of the last several inches of the colon. Together,
More informationGrand Rounds. Des Moines University. May 5, Durado Brooks, MD, MPH Director, Cancer Control Intervention American Cancer Society
Grand Rounds Des Moines University May 5, 2016 Durado Brooks, MD, MPH Director, Cancer Control Intervention American Cancer Society Case Summary Mrs. J is a 56 y o w female complaining of always tired;
More informationHow to Increase Preventive Screening Rates in Practice: An Action Plan for Implementing A Primary Care Clinician s Evidence-Based Toolbox and Guide
How to Increase Preventive Screening Rates in Practice: An Action Plan for Implementing A Primary Care Clinician s Evidence-Based Toolbox and Guide CRC Toolkit and Guide Available at http://www.cancer.org/aspx/pcmanual/pcm.swf
More informationColorectal Cancer Screening
Colorectal Cancer Screening An Integrated Care Pathway of the Collaborative Care Network Subject Matter Expert: Kevin Wolov, DO Pathway Custodian: Pat Czapp, MD First, a Friendly Reminder... This Integrated
More informationCancer Screening 2009: Setting Evidence-based Priorities
Cancer Screening 2009: Setting Evidence-based Priorities Eliseo J. Pérez-Stable, MD Professor of Medicine Department of Medicine Division of General Internal Medicine University of California, San Francisco
More informationColorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer Douglas K. Rex, MD, MACG 1, C. Richard Boland, MD 2, Jason A. Dominitz,
More informationColorectal Cancer Screening
Colorectal Cancer Screening Colonoscopy is the gold standard for colorectal cancer screening 2 Focus on Colorectal Cancer Screening at Piedmont Healthcare Screening for colorectal cancer saves lives. Of
More informationACTIVITY DISCLAIMER DISCLOSURE. Alvin B. Lin, MD, FAAFP. Audience Engagement System Step 1 Step 2 Step 3. Learning Objectives.
ACTIVITY DISCLAIMER Colorectal Cancer Alvin B. Lin, MD, FAAFP The material presented here is being made available by the American Academy of Family Physicians for educational purposes only. Please note
More informationQuality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care
Quality ID #113 (NQF 0034): Colorectal Cancer Screening National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Process DESCRIPTION: Percentage
More informationONCOLOGY OUTCOMES REPORT
2017 EVANGELICAL COMMUNITY HOSPITAL ONCOLOGY OUTCOMES REPORT One Hospital Drive, Lewisburg, PA 17837 570-522-2000 evanhospital.com Cancer Screening The Commission on Cancer requires annual dissemination
More informationIn its October 5, 2015, draft recommendation (draft
USPSTF Colorectal Cancer Screening Guidelines: An Extended Look at Multi-Year Interval Testing Barry M. Berger, MD, FCAP; Marcus A. Parton, SB; and Bernard Levin, MD, FACP Managed Care & Healthcare Communications,
More informationCANCER SCREENING. Er Chaozer Department of General Medicine, Tan Tock Seng Hospital
CANCER SCREENING Er Chaozer Department of General Medicine, Tan Tock Seng Hospital Introduction Screening average risk patients Benefits and harms from screening Early cancer detection early treatment
More informationScreening for Colon Cancer: How best and how effective? Richard Rosenberg, MD Assistant Professor of Medicine Columbia University Medical Center
Screening for Colon Cancer: How best and how effective? Richard Rosenberg, MD Assistant Professor of Medicine Columbia University Medical Center Colorectal Cancer Overview Joint Guideline: American Cancer
More informationA PROVIDER S GUIDE TO PREVENTIVE HEALTH SERVICES FOR YOUR PATIENTS
ConnectiCare, together with the Centers for Medicare & Medicaid Services, encourages the use of preventive health services. For certain basic preventive health services, ConnectiCare Medicare Plan beneficiaries
More informationCancer Screening I have no conflicts of interest. Principles of screening. Cancer in the World Page 1. Letting Evidence Be Our Guide
Cancer Screening 2012 Letting Evidence Be Our Guide Jeffrey A. Tice, MD Division of General Internal Medicine University of California, San Francisco I have no conflicts of interest Principles of screening
More informationA PROVIDER S GUIDE TO PREVENTIVE HEALTH SERVICES FOR YOUR PATIENTS
ConnectiCare, together with the Centers for Medicare & Medicaid Services, encourages the use of preventive health services. For certain basic preventive health services, ConnectiCare Medicare Plan beneficiaries
More informationQuality ID #439: Age Appropriate Screening Colonoscopy National Quality Strategy Domain: Efficiency and Cost Reduction
Quality ID #439: Age Appropriate Screening Colonoscopy National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Efficiency DESCRIPTION:
More informationKenneth D. Chi, MD Medical Director, GI Lab Advocate Lutheran General Hospital Center for Digestive Health May 7, 2016
Kenneth D. Chi, MD Medical Director, GI Lab Advocate Lutheran General Hospital Center for Digestive Health May 7, 2016 Why have Quality Indicators? Pre-procedure Quality Indicators Intra-procedure Quality
More informationCOLORECTAL CANCER SCREENING COLLABORATIVE FINAL REPORT September 2012
COLORECTAL CANCER SCREENING COLLABORATIVE FINAL REPORT September 2012 INTRODUCTION/HISTORY OF PROJECT Colon cancer is easily treated and often cured when caught in the early stages. Yet, it remains the
More informationUpdates In Cancer Screening: Navigating a Changing Landscape
Updates In Cancer Screening: Navigating a Changing Landscape Niharika Dixit, MD I have no conflict of interest. 1 Why Should You Care Trends in Cancer Incidence by Site United States. Siegal Et al: CA
More informationColorectal Cancer Screening
Scan for mobile link. Colorectal Cancer Screening What is colorectal cancer screening? Screening examinations are tests performed to identify disease in individuals who lack any signs or symptoms. The
More informationImproving Access to Endoscopy at Safety-Net Hospitals. Lukejohn W. Day MD Assistant Professor of Medicine
Improving Access to Endoscopy at Safety-Net Hospitals Lukejohn W. Day MD Assistant Professor of Medicine Goals Background Improving Access to Endoscopic Care Electronic referral: ereferral Direct Access
More informationIEHP UM Subcommittee Approved Authorization Guidelines Colorectal Cancer Screening with Cologuard TM for Medicare Beneficiaries
for Medicare Beneficiaries Policy: Based on our review of the available evidence, the IEHP UM Subcommittee adopts the use of Cologuard TM - a multi-target stool DNA test as a colorectal cancer screening
More informationColorectal cancer screening: Is total prevention possible?
Just the facts colorectal cancer Colorectal cancer screening: Is total prevention possible? Jeffrey Fox, MD, MPH Concepts and Controversies 2011 2010 NCI estimates for US: 142, 570 new CRC diagnoses 51,370
More informationMeasure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care
Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: The
More informationGet tested for. Colorectal cancer. Doctors know how to prevent colon or rectal cancer- and you can, too. Take a look inside.
Get tested for Colorectal cancer Doctors know how to prevent colon or rectal cancer- and you can, too. Take a look inside. 1 If you re 50 or older, you need to get tested for colorectal cancer. It s one
More informationJoint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D.
Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies Ashish Sangal, M.D. Cancer Screening: Consensus & Controversies Ashish Sangal, MD Director,
More information